Benserazide is a carbohydrazide-based, peripherally acting inhibitor of aromatic L-amino acid decarboxylase or DOPA
decarboxylase and a medication used in combination with levodopa (madopar) to treat Parkinson's disease, parkinsonism, and restless leg syndrome.
纯度:≥98%
CAS:322-35-0